tiprankstipranks
Trending News
More News >

China Traditional Chinese Medicine’s Yushuda Tablets Gain NMPA Acceptance

Story Highlights
  • China Traditional Chinese Medicine focuses on innovative traditional Chinese medicinal products.
  • NMPA accepted the new drug application for Yushuda Tablets, advancing regulatory review.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
China Traditional Chinese Medicine’s Yushuda Tablets Gain NMPA Acceptance

Don’t Miss TipRanks’ Half-Year Sale

China Traditional Chinese Medicine Holdings Co ( (HK:0570) ) has issued an update.

China Traditional Chinese Medicine Holdings Co. Limited announced that the National Medical Products Administration of China has accepted the new drug application for Yushuda Tablets, an innovative traditional Chinese medicine developed by its subsidiary, Sinopharm Group Tongjitang Pharmaceutical. Yushuda Tablets have shown significant efficacy in treating mild-to-moderate depression, particularly symptoms related to qi stagnation. The acceptance marks a critical step in the regulatory process, although the timeline for approval remains uncertain, and the company advises caution to shareholders and investors.

The most recent analyst rating on (HK:0570) stock is a Buy with a HK$5.00 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.

More about China Traditional Chinese Medicine Holdings Co

China Traditional Chinese Medicine Holdings Co. Limited operates in the traditional Chinese medicine industry, focusing on the development and production of innovative traditional Chinese medicinal products. The company is involved in creating treatments that address various health issues, with a market focus on traditional Chinese medicine.

Average Trading Volume: 28,127,140

Technical Sentiment Signal: Sell

Current Market Cap: HK$11.13B

See more data about 0570 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1